Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice
KG Samsom, LJ Schipper, P Roepman… - The Journal of …, 2022 - Wiley Online Library
The current increase in number and diversity of targeted anticancer agents poses
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice
KG Samsom, LJ Schipper… - Journal of …, 2022 - researchinformation.amsterdamumc …
The current increase in number and diversity of targeted anticancer agents poses
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
[PDF][PDF] Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice
KG Samsom, LJ Schipper, P Roepman… - J …, 2022 - researchinformation.umcutrecht.nl
The current increase in number and diversity of targeted anticancer agents poses
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
[HTML][HTML] Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice
KG Samsom, LJ Schipper, P Roepman… - The Journal of …, 2022 - ncbi.nlm.nih.gov
The current increase in number and diversity of targeted anticancer agents poses
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice.
KG Samsom, LJ Schipper, P Roepman… - The Journal of …, 2022 - europepmc.org
The current increase in number and diversity of targeted anticancer agents poses
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice
KG Samsom, LJ Schipper… - The Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
The current increase in number and diversity of targeted anticancer agents poses
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice.
KG Samsom, LJ Schipper, P Roepman… - Journal of …, 2022 - search.ebscohost.com
The current increase in number and diversity of targeted anticancer agents poses
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice.
KG Samsom, LJ Schipper, P Roepman… - The Journal of …, 2022 - europepmc.org
The current increase in number and diversity of targeted anticancer agents poses
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …